Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.
about
Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor alpha by inhibiting NF-kappaB signaling pathwayOxidative stress and cytokines in the pathogenesis of pancreatic cancerTumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancerExploiting inflammation for therapeutic gain in pancreatic cancerInvestigation of Tumor Cell Behaviors on a Vascular Microenvironment-Mimicking Microfluidic Chip.Tumor necrosis factor alpha promotes the proliferation of human nucleus pulposus cells via nuclear factor-κB, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinaseSelective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression.Assessment of anti-inflammatory tumor treatment efficacy by longitudinal monitoring employing sonographic micro morphology in a preclinical mouse modelEffect of cigarette smoke exposure and mutant Kras overexpression on pancreatic cell proliferation.Subdiaphragmatic vagotomy promotes tumor growth and reduces survival via TNFα in a murine pancreatic cancer model.Chronic inflammation and cytokines in the tumor microenvironment.Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML.TNF-α promotes gallbladder cancer cell growth and invasion through autocrine mechanismsPost-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements.Discovering the route from inflammation to pancreatic cancer.Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer.Tumor necrosis factor-α attenuates starvation-induced apoptosis through upregulation of ferritin heavy chain in hepatocellular carcinoma cellsTumor necrosis factor induces tumor promoting and anti-tumoral effects on pancreatic cancer via TNFR1.Lipid Signaling in Tumorigenesis.CD44 and HCELL: preventing hematogenous metastasis at step 1.P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells.Tumor necrosis factor-alpha promotes survival in methotrexate-exposed macrophages by an NF-kappaB-dependent pathway.Effects of ketamine, s-ketamine, and MK 801 on proliferation, apoptosis, and necrosis in pancreatic cancer cells.Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review.Prostate carcinogenesis with diabetes and androgen-deprivation-therapy-related diabetes: an updateIncreased tumor necrosis factor receptor 1 expression in human colorectal adenomas.The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responsesTNF-α gene knockout in triple negative breast cancer cell line induces apoptosis.Disrupting cytokine signaling in pancreatic cancer: a phase I/II study of etanercept in combination with gemcitabine in patients with advanced diseaseInflammation: a driving force speeds cancer metastasisTumor necrosis factor and cancer, buddies or foes?Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells.Current and potential inflammation targeted therapies in head and neck cancer.Infliximab enhances the therapeutic effects of 5-fluorouracil resulting in tumor regression in colon cancer.Monoclonal antibodies in the treatment of pancreatic cancer.The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans.Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population.The diverse roles of the TNF axis in cancer progression and metastasis.Use of infliximab in particular clinical settings: management based on current evidence.Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.
P2860
Q21245702-F9C6B6F8-47B7-4EFB-8ACA-D88D022DC503Q26824025-8A7F6B55-5BFA-4F9A-A067-0B84D20393DEQ27021391-3F949956-0A28-45B9-B688-8E5001EFE022Q27027661-1D6850BB-9D09-4C5D-A2FE-A3EBE4782095Q27304419-772C7606-C72A-40A6-B03C-740160B94E77Q28383452-7759B6D3-7387-4908-986A-BEBFA751ACD6Q30384798-88708CAF-A9C5-4D50-BBB1-CAAEF77E6DFCQ31020210-E4EEE09B-7C5A-4475-AE51-D7F34F2989C1Q33599346-09E7F352-D29D-4D4F-BCE6-616534ED5758Q33618379-4724F619-BE99-43A2-B141-A17CCDA303C0Q33678275-4A2132E3-59D3-4C66-A416-51AA9CC810D7Q33703030-282F33E6-4D40-4B53-823F-5C2650757405Q33747708-BE768DC2-3C5F-4885-A98B-807801FBEAF5Q34065213-7EF9F09A-C7D0-4488-ABE9-77CBA5456EEEQ34645978-3D51FC3B-9231-4159-9BBB-F601C9EE8A3FQ34681333-E91F8A28-D024-4A84-BF50-7F6E9B0225B1Q34997635-C4BEA830-10B0-4D50-B340-B31D309A5465Q35010079-E3404348-8A12-4AA6-8BA3-D5F26F6FB474Q35136532-A4273561-FDE8-4C8F-8317-AB8138760FE5Q35376738-E9762037-95FA-4985-BFB2-D77AC1CED713Q35521224-C40D460B-0AA9-4385-A3F0-981699B23EC6Q35620332-3915A282-C01F-4279-8059-549DEFE8D41EQ35720701-B263AFAD-8131-41B1-BC1C-64D9A4FE250CQ36015280-8E94B263-A6D5-4075-A1CA-DCEE1C82283EQ36076214-2DE5824F-5C25-4E3B-A659-BD6A0668C86FQ36316684-A6532A05-2F56-4CF6-AAFB-E69A4A34FF84Q36436005-FBF64F5E-B00A-47F6-9C66-976DDB23BA86Q36589909-11BCD9BE-404A-4921-9FDF-04EA3D8E3B93Q36876297-B37AD96F-7634-4003-BCD7-D21B473A81D1Q36986448-DB250556-2AFC-44C6-9B96-BB7DD727F659Q37073092-D04EC0E8-9152-45CF-B313-AFF8C84304F4Q37200457-A7DDA7A6-3112-438E-8A69-96C96778A423Q37316179-25E4E4D4-357E-4631-B97A-52157EF672A7Q37320785-6EDF94F0-BA3B-4556-9A2A-9272282B7F48Q37355568-5621D920-D42A-42D1-94EF-C80198676810Q37363065-9A65F684-ABA4-4AFC-9DD4-5E68F067F71EQ37446478-ECB11868-1602-4F8B-8A62-D5D930F919BFQ37474735-6C137902-DE8A-4E32-A624-1B8DE4F2A38FQ37506064-AC38F955-CBE1-430C-83D5-8A2F3D6505FCQ37524210-9771B5F6-3275-4861-B9AC-83EBBA0D04EB
P2860
Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.
@en
type
label
Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.
@en
prefLabel
Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.
@en
P2093
P50
P1433
P1476
Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.
@en
P2093
Andreas Noack
Bastian Kettler
Bodo Schniewind
Christian Kneitz
Holger Kalthoff
Jürgen Tepel
Stefanie Klose
Vera Cloosters
P304
P356
10.1158/0008-5472.CAN-07-5704
P407
P577
2008-03-01T00:00:00Z